Deafness: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Deafness}}
{{Deafness}}
'''For patient information, click [[Encopresis (patient information)|here]]'''
'''For patient information, click [[Deafness (patient information)|here]]'''


{{CMG}} {{AE}} {{SME}}
{{CMG}} {{AE}} {{SME}}

Latest revision as of 05:19, 30 April 2013

Deafness Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Type page name here from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Identity and Culture

Terminology

Diagnosis

History and Symptoms

Physical Examination

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Deafness On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Deafness

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Deafness

CDC on Deafness

Deafness in the news

Blogs on Deafness

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Deafness

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saumya Easaw, M.B.B.S.[2]

International Symbol for Deafness

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Encopresis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Identity and Culture

Terminology

Diagnosis

History and Symptoms | Physical Examination | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

See also